First Citizens Bank & Trust Co. acquired a new position in shares of Steris PLC (NYSE:STE) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,160 shares of the medical equipment provider’s stock, valued at approximately $476,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of STE. WCM Investment Management CA purchased a new position in Steris during the 2nd quarter worth $107,609,000. Renaissance Technologies LLC purchased a new position in Steris during the 2nd quarter worth $25,843,000. Fiera Capital Corp purchased a new position in Steris during the 2nd quarter worth $25,099,000. BlackRock Inc. boosted its holdings in Steris by 1.8% during the 2nd quarter. BlackRock Inc. now owns 7,608,114 shares of the medical equipment provider’s stock worth $798,929,000 after acquiring an additional 131,142 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in Steris by 1,253.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 140,082 shares of the medical equipment provider’s stock worth $14,710,000 after acquiring an additional 129,729 shares during the last quarter. 88.79% of the stock is currently owned by hedge funds and other institutional investors.

STE has been the topic of a number of analyst reports. Zacks Investment Research raised shares of Steris from a “sell” rating to a “hold” rating in a report on Tuesday, October 9th. JMP Securities lifted their target price on Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a research note on Thursday, August 9th. Stephens reiterated a “buy” rating and set a $125.00 target price on shares of Steris in a research note on Thursday, August 9th. Finally, KeyCorp lifted their target price on Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 9th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $100.86.

In other news, VP Karen L. Burton sold 1,300 shares of Steris stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $114.39, for a total transaction of $148,707.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 2.38% of the company’s stock.

NYSE STE opened at $106.68 on Friday. The firm has a market cap of $9.30 billion, a PE ratio of 25.71 and a beta of 1.06. Steris PLC has a one year low of $82.88 and a one year high of $117.48. The company has a current ratio of 2.65, a quick ratio of 2.02 and a debt-to-equity ratio of 0.43.

Steris (NYSE:STE) last released its earnings results on Wednesday, August 8th. The medical equipment provider reported $1.00 EPS for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.01. The company had revenue of $638.76 million for the quarter, compared to analysts’ expectations of $638.63 million. Steris had a return on equity of 11.80% and a net margin of 11.42%. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.85 EPS. As a group, sell-side analysts forecast that Steris PLC will post 4.71 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 27th. Stockholders of record on Wednesday, August 29th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.27%. This is a boost from Steris’s previous quarterly dividend of $0.31. The ex-dividend date was Tuesday, August 28th. Steris’s payout ratio is presently 32.77%.

About Steris

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: The benefits and drawbacks of dollar cost averaging

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.